| |
Overall N = 59
|
Bath1 N = 19
|
Bath2 N = 21
|
Control N = 19
|
P
|
|---|
|
Gender (female/male)
|
29/30
|
5/14
|
14/7
|
10/9
|
0.04*a
|
|
Age (years)
|
57.6 (9.6)
|
60.2 (6.7)
|
57.1 (10.0)
|
55.5 (11.4)
|
0.32
|
|
Patients taking antihypertensive medication (n)
|
33 (55.9 %)
|
11 (57.9 %)
|
7 (33.3 %)
|
15 (78.9 %)
|
0.02*a
|
|
No CVRF (n)
|
2
|
0
|
2
|
0
|
0.46a
|
|
1–2 CVRF (n)
|
32
|
9
|
13
|
10
|
|
≥3 CVRF (n)
|
22
|
9
|
5
|
8
|
|
CVD (n)
|
3
|
1
|
1
|
1
|
|
Smoking status (smoker/non-smoker)
|
9/50 (15 %)
|
1/18 (5 %)
|
4/17 (19 %)
|
4/15 (21 %)
|
0.33a
|
|
SBP (mm Hg)
|
145.2 (10.2)
|
147.2 (7.8)
|
143.8 (12.3)
|
144.8 (9.9)
|
0.55
|
|
DBP (mm Hg)
|
90.1 (8.5)
|
91.8 (8.4)
|
90.5 (9.9)
|
88.1 (7.0)
|
0.42
|
|
BMI (kg/m2)
|
29.5 (5.7)
|
29.9 (5.3)
|
27.4 (5.3)
|
31.3 (5.9)
|
0.08
|
|
Waist circumference (cm)
|
102.0 (13.0)
|
106.0 (14.0)
|
98.0 (13.0)
|
103.0 (11.0)
|
0.20
|
|
Cholesterol total (mg/dl) (50–200)
|
226.0 (36.0)
|
219.0 (38.0)
|
230.0 (35.0)
|
227.0 (36.0)
|
0.63
|
|
LDL (mg/dl) (<160)
|
138.0 (33.0)
|
135.0 (33.0)
|
143.0 (31.0)
|
137.0 (35.0)
|
0.72
|
|
HDL (mg/dl) (>40)
|
48.0 (15.0)
|
47.0 (13.0)
|
51.0 (15.0)
|
44.0 (15.0)
|
0.28
|
|
LDL/HDL Quotient (<3)
|
3.2 (1.3)
|
2.9 (0.9)
|
3.1 (1.5)
|
3.5 (1.5)
|
0.38
|
|
Triglyceride (mg/dl) (<150)
|
153.0 (88.0)
|
168.0 (107.0)
|
126.0 (56.0)
|
168.0 (95.0)
|
0.22
|
|
CRP (mg/l) (0–5)
|
2.7 (2.3)
|
2.5 (2.3)
|
2.3 (2.3)
|
3.3 (2.3)
|
0.36
|
|
Fasting blood glucose (mg/dl) (70–110)
|
99.0 (23.0)
|
110.0 (30.0)
|
90.0 (18.0)
|
95.0 (15.0)
|
0.02*
|
- Data are shown as mean and standard deviation (SD)
- *P < 0.05
-
BMI body mass index, CVRF cardiovascular risk factors, CVD cardiovascular disease, SBP systolic blood pressure, DBP diastolic blood pressure, CRP C-reactive protein
-
aChi2-test
